Seth Loring Harrison

CIK 1404955 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$511.76M

Companies

4

Total Filings

69

Lifetime Open-Market Net

-$52.02M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STOK Director 17,161,713 $29.82 $511.76M $39.63M 10 2026-06-05
Akero Therapeutics, Inc. (AKRO) Delisted Director 0 $54.65 $0 $14.28M 13 2025-12-09
HeartWare International, Inc. (HTWR) Delisted Director 0 -$111.36M 31 2016-08-24
Eledon Pharmaceuticals, Inc. (TKAI) Delisted Director 8,124,773 $5.44M 3 2016-06-16

Recent Filings · Page 7 of 7

69 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-09-05 Buy (P) +20,000 $9.8K
2008-09-02 Buy (P) +25,000 $12.5K
2008-08-26 Buy (P) +680,198 $346.9K
2008-08-25 Buy (P) +33,649 $17.8K
2008-08-22 Buy (P) +184,453 $95.9K
2008-08-21 Buy (P) +101,700 $51.9K
2008-08-21 Buy (P) +164,500 $85.5K
2008-08-18 Buy (P) +164,500 $85.5K
2008-08-13 Buy (P) +735,500 $382.5K
Showing 6169 of 69
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.